Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,460 | 13,540 | 19,215 | -3,142 | -18,032 |
| Depreciation Amortization | 2,472 | 1,941 | 1,227 | 543 | 1,921 |
| Accounts receivable | 5,491 | 2,223 | 760 | 127 | -2,509 |
| Accounts payable and accrued liabilities | -3,700 | -3,998 | -1,832 | -1,556 | -386 |
| Other Working Capital | -58,169 | -59,538 | -55,630 | -16,237 | -41,030 |
| Other Operating Activity | 6,241 | 8,036 | 5,779 | 3,680 | 8,956 |
| Operating Cash Flow | $-42,206 | $-37,796 | $-30,480 | $-16,585 | $-51,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,492 | -1,394 | -938 | -666 | -828 |
| Purchase Of Investment | -149,371 | -117,106 | -112,097 | -15,073 | -125,027 |
| Sale Of Investment | 82,302 | 49,171 | 19,589 | 12,040 | 195,147 |
| Investing Cash Flow | $-68,560 | $-69,329 | $-93,447 | $-3,699 | $69,292 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 103,495 | 102,889 | 102,677 | 292 | 645 |
| Common Stock Repurchased | -4 | -4 | N/A | 0 | N/A |
| Financing Cash Flow | $103,491 | $102,885 | $102,677 | $292 | $645 |
| Exchange Rate Effect | -39 | -34 | -29 | 1 | -7 |
| Beginning Cash Position | 52,847 | 52,847 | 52,847 | 52,847 | 33,997 |
| End Cash Position | 45,533 | 48,572 | 31,569 | 32,855 | 52,847 |
| Net Cash Flow | $-7,314 | $-4,275 | $-21,278 | $-19,992 | $18,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,206 | -37,796 | -30,480 | -16,585 | -51,081 |
| Capital Expenditure | -1,502 | -1,394 | -938 | -666 | -828 |
| Free Cash Flow | -43,708 | -39,190 | -31,418 | -17,251 | -51,908 |